) in a stock deal, the Wall Street Journal reported on Saturday, citing people familiar with the matter.
Mylan shareholders would receive a little more than 40% of the newly formed entity, with Pfizer shareholders receiving the remainder, the Journal said, adding Pfizer would also get about $12 billion in proceeds from a new sale of debt.Reporting by Maria Ponnezhath in Bengaluru; Editing by Mark Potter
Abbiamo riassunto questa notizia in modo che tu possa leggerla velocemente. Se sei interessato alla notizia puoi leggere il testo completo qui. Leggi di più:
Further consolidation that will result in increased drug prices. Republicans will say this is free market principals. Americans will blame Democrats either way.
Italia Ultime Notizie, Italia Notizie
Similar News:Puoi anche leggere notizie simili a questa che abbiamo raccolto da altre fonti di notizie.
Pfizer Nears Deal to Combine off-Patent Drug Business With MylanPfizer is in talks to merge its off-patent drugs business with generic drugmaker Mylan, in a deal that would create a giant global seller of lower-priced medicines. Sr. lopez atención sr. lopez..... Se necesitán medicamentos en méxico... Atención jonathanrockoff so that they can raise the price? Ha ha ha. Lower prices. Ha ha ha. Methinks I've heard that before. Ha ha ha.
Fonte: WSJ - 🏆 98. / 63 Leggi di più »
Pfizer Nears Deal to Combine off-Patent Drug Business With MylanPfizer is in talks to merge its off-patent drugs business with generic drugmaker Mylan, in a deal that would create a giant global seller of lower-priced medicines. Sr. lopez atención sr. lopez..... Se necesitán medicamentos en méxico... Atención jonathanrockoff so that they can raise the price? Ha ha ha. Lower prices. Ha ha ha. Methinks I've heard that before. Ha ha ha.
Fonte: WSJ - 🏆 98. / 63 Leggi di più »
There's no business like the arms business: Here's how the top US defense companies did in Q2 earningsNobody spends money on arms like the United States, and it shows in the bottom lines of the biggest defense contractors. 'While the companies’ quarterly performances remained strong, collectively their stocks were largely unchanged. The iShares U.S. Aerospace and Defense ETF was slightly higher for this week after the companies reported. So far this year the benchmark ETF is up nearly 26 percent.'
Fonte: CNBC - 🏆 12. / 72 Leggi di più »